Retracted: Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines.

4区医学 Q2 Medicine

Evidence-based Complementary and Alternative Medicine Pub Date : 2023-12-13 eCollection Date: 2023-01-01 DOI:10.1155/2023/9787205

Evidence-Based Complementary And Alternative Medicine

引用次数: 0

Abstract

[This retracts the article DOI: 10.1155/2022/8060026.].

查看原文本刊更多论文

撤稿：阿帕替尼联合S-1疗法治疗晚期胃癌患者的疗效及其对肿瘤标志物、Th1和Th2类细胞因子水平的影响

[本文撤回了文章 DOI：10.1155/2022/8060026.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Evidence-based Complementary and Alternative Medicine 医学-全科医学与补充医学

自引率

0.00%

发文量

1983

审稿时长

2.2 months

期刊介绍： Evidence-Based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research in this new, yet ancient world of complementary and alternative medicine. The journal seeks to apply scientific rigor to the study of complementary and alternative medicine (CAM) modalities, particularly traditional Asian healing systems. eCAM emphasizes health outcome, while documenting biological mechanisms of action. The journal is devoted to the advancement of science in the field of basic research, clinical studies, methodology or scientific theory in diverse areas of Biomedical Sciences. The journal does not consider articles on homeopathy.